Syndax Pharmaceuticals (SNDX) Institutional Ownership

Of the 206 institutional investors that purchased Syndax Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BlackRock Inc. ($9.02M), Bank of America Corp DE ($5.01M), Elmind Capital LP ($3.71M), California State Teachers Retirement System ($1.97M), Soleus Capital Management L.P. ($1.91M), Assenagon Asset Management S.A. ($1.64M), and Eventide Asset Management LLC ($1.27M).

Institutional investors have bought a total of 35,688,107 shares in the last 24 months. This purchase volume represents approximately $752.65M in transactions.

Of the 68 institutional investors that sold Syndax Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Assenagon Asset Management S.A. ($2.00M), Granahan Investment Management LLC ($685.07K), Bank of America Corp DE ($602.03K), Eversept Partners LP ($581.69K), Millennium Management LLC ($552.16K), Dimensional Fund Advisors LP ($459.34K), and Catalio Capital Management LP ($417.91K).

Institutional investors have sold a total of 9,754,118 shares in the last 24 months. This volume of shares sold represents approximately $184.63M in transactions.